Abstract:Introduction: Distinguishing Parkinson's disease (PD) from Progressive supranuclear palsy (PSP) at early disease stages is important for clinical trial enrollment and clinical care/prognostication. Methods: We recruited 21 participants with PSP(n = 11) or PD(n = 10) with reliable caregivers. Standardized passage reading, counting, and sustained phonation were recorded on the BioDigit Home tablet (BioSensics LLC, Newton, MA USA), and speech features from the assessments were analyzed using the BioDigit Speech platform (BioSensics LLC, Newton, MA USA). An independent t-test was performed to compare each speech feature between PSP and PD participants. We also performed Spearman's correlations to evaluate associations between speech measures and clinical scores (e.g., PSP rating scales and MoCA). In addition, the model's performance in classifying PSP and PD was evaluated using Rainbow passage reading analysis. Results: During Rainbow passage reading, PSP participants had a significantly slower articulation rate (2.45(0.49) vs 3.60(0.47) words/minute), lower speech-to-pause ratio (2.33(1.08) vs 3.67(1.18)), intelligibility dynamic time warping (DTW, 0.26(0.19) vs 0.53(0.26)), and similarity DTW (0.43(0.27) vs 0.67(0.13)) compared to PD participants. PSP participants also had longer pause times (17.24(5.47) vs 8.45(3.13) sec) and longer total signal times (52.44(6.67) vs (36.67(6.73) sec) when reading the passage. In terms of the phonation 'a', PSP participants showed a significant higher spectral entropy, spectral centroid, and spectral spread compared to PD participants and no differences were found for phonation 'e'. PD participants had more accurate reverse number counts than PSP participants (14.89(3.86) vs 7.36(4.67)). PSP Rating Scale (PSPRS) dysarthria (r = 0.79, p = 0.004) and bulbar item scores (r = 0.803, p = 0.005) were positively correlated with articulation rate in reverse number counts. Correct reverse number counts were positively correlated with total Montreal Cognitive Assessment scores (r = 0.703, p = 0.016). Machine learning models using passage reading-derived measures obtained an AUC of 0.93, and the sensitivity/specificity in correctly classifying PSP and PD participants were 0.95 and 0.90, respectively. Conclusion: Our study demonstrates the feasibility of differentiating PSP from PD using a digital health technology platform. Further multi-center studies are needed to expand and validate our initial findings.

A Portable Automatic PA-TA-KA Syllable Detection System to Derive Biomarkers for Neurological Disorders

PDAssess: A Privacy-preserving Free-speech Based Parkinson's Disease Daily Assessment System

An Intelligent Mobile-Enabled System for Diagnosing Parkinson Disease: Development and Validation of a Speech Impairment Detection System

Utilizing speech analysis to differentiate progressive supranuclear palsy from Parkinson's disease

Detecting Parkinson's Disease From an Online Speech-task

Automatic speech-based assessment to discriminate Parkinson's disease from essential tremor with a cross-language approach

An automatic measure for speech intelligibility in dysarthrias-validation across multiple languages and neurological disorders

Automatic Estimation Of Parkinson'S Disease Severity From Diverse Speech Tasks

Speech as a Biomarker for Disease Detection

Speech's syllabic rhythm and articulatory features produced under different auditory feedback conditions identify Parkinsonism

Smartphone automated motor and speech analysis for early detection of Alzheimer's disease and Parkinson's disease: Validation of TapTalk across 20 different devices

Toward Automated Articulation Rate Analysis via Connected Speech in Dysarthrias

Machine Learning-Assisted Speech Analysis for Early Detection of Parkinson's Disease: A Study on Speaker Diarization and Classification Techniques

Machine Learning Smart System for Parkinson Disease Classification Using the Voice as a Biomarker

Toolkit to Examine Lifelike Language v.2.0: Optimizing Speech Biomarkers of Neurodegeneration

Assessment of Parkinson's Disease Medication State through Automatic Speech Analysis

Ensemble Machine Learning Approach for Parkinson's Disease Detection Using Speech Signals

Multimodal Speech Biomarkers for Remote Monitoring of ALS Disease Progression

Automatic detection of ALS from single-trial MEG signals during speech tasks: a pilot study

Using Objective Speech Analysis Techniques for the Clinical Diagnosis and Assessment of Speech Disorders in Patients with Multiple Sclerosis

Assessing clinical utility of Machine Learning and Artificial Intelligence approaches to analyze speech recordings in Multiple Sclerosis: A Pilot Study